These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32723380)

  • 21. Lung cancer risk and residential radon exposure: A pooling of case-control studies in northwestern Spain.
    Lorenzo-Gonzalez M; Ruano-Ravina A; Torres-Duran M; Kelsey KT; Provencio M; Parente-Lamelas I; Piñeiro-Lamas M; Varela-Lema L; Perez-Rios M; Fernandez-Villar A; Barros-Dios JM
    Environ Res; 2020 Oct; 189():109968. PubMed ID: 32736146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of the North American residential radon and lung cancer case-control studies.
    Field RW; Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
    J Toxicol Environ Health A; 2006 Apr; 69(7):599-631. PubMed ID: 16608829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case-referent study of lung cancer and incense smoke, smoking, and residential radon in Chinese men.
    Tse LA; Yu IT; Qiu H; Au JS; Wang XR
    Environ Health Perspect; 2011 Nov; 119(11):1641-6. PubMed ID: 22067552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies.
    Lubin JH; Boice JD
    J Natl Cancer Inst; 1997 Jan; 89(1):49-57. PubMed ID: 8978406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Residential radon and lung cancer. An ecologic study in Galicia, Spain].
    Barbosa-Lorenzo R; Ruano-Ravina A; Cerdeira Caramés S; Barros-Dios JM
    Med Clin (Barc); 2015 Apr; 144(7):304-8. PubMed ID: 24485165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung cancer and residential radon in never-smokers: A pooling study in the Northwest of Spain.
    Lorenzo-González M; Ruano-Ravina A; Torres-Durán M; Kelsey KT; Provencio M; Parente-Lamelas I; Leiro-Fernández V; Vidal-García I; Castro-Añón O; Martínez C; Golpe-Gómez A; Zapata-Cachafeiro M; Piñeiro-Lamas M; Pérez-Ríos M; Abal-Arca J; Montero-Martínez C; Fernández-Villar A; Barros-Dios JM
    Environ Res; 2019 May; 172():713-718. PubMed ID: 30903971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residential radon and lung cancer: a cohort study in Galicia, Spain.
    Barbosa-Lorenzo R; Ruano-Ravina A; Cerdeira-Caramés S; Raíces-Aldrey M; Barros-Dios JM
    Cad Saude Publica; 2017 Jul; 33(6):e00189415. PubMed ID: 28678939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residential radon and lung cancer risk: an updated meta- analysis of case-control studies.
    Zhang ZL; Sun J; Dong JY; Tian HL; Xue L; Qin LQ; Tong J
    Asian Pac J Cancer Prev; 2012; 13(6):2459-65. PubMed ID: 22938404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression Quantitative Trait loci (QTL) in tumor adjacent normal breast tissue and breast tumor tissue.
    Quiroz-Zárate A; Harshfield BJ; Hu R; Knoblauch N; Beck AH; Hankinson SE; Carey V; Tamimi RM; Hunter DJ; Quackenbush J; Hazra A
    PLoS One; 2017; 12(2):e0170181. PubMed ID: 28152060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radon Exposure-Therapeutic Effect and Cancer Risk.
    Maier A; Wiedemann J; Rapp F; Papenfuß F; Rödel F; Hehlgans S; Gaipl US; Kraft G; Fournier C; Frey B
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
    Yau C; Benz CC
    Breast Cancer Res; 2008; 10(4):R61. PubMed ID: 18631401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
    Liu D; Zhou K
    Clin Breast Cancer; 2020 Feb; 20(1):41-50.e8. PubMed ID: 31547956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residential radon exposure, histologic types, and lung cancer risk. A case-control study in Galicia, Spain.
    Barros-Dios JM; Ruano-Ravina A; Pérez-Ríos M; Castro-Bernárdez M; Abal-Arca J; Tojo-Castro M
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):951-8. PubMed ID: 22539606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residential radon and lung cancer: end of the story?
    Samet JM
    J Toxicol Environ Health A; 2006 Apr; 69(7):527-31. PubMed ID: 16608827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radon.
    Rep Carcinog; 2004; 11():III152-4. PubMed ID: 21089894
    [No Abstract]   [Full Text] [Related]  

  • 36. Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.
    Alles MC; Gardiner-Garden M; Nott DJ; Wang Y; Foekens JA; Sutherland RL; Musgrove EA; Ormandy CJ
    PLoS One; 2009; 4(3):e4710. PubMed ID: 19270750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residential radon and lung cancer among never-smokers in Sweden.
    Lagarde F; Axelsson G; Damber L; Mellander H; Nyberg F; Pershagen G
    Epidemiology; 2001 Jul; 12(4):396-404. PubMed ID: 11416777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment and management of residential radon health risks: a report from the health Canada radon workshop.
    Tracy BL; Krewski D; Chen J; Zielinski JM; Brand KP; Meyerhof D
    J Toxicol Environ Health A; 2006 Apr; 69(7):735-58. PubMed ID: 16608836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
    Chen XQ; Zhang F; Su QC; Zeng C; Xiao FH; Peng Y
    Clin Epigenetics; 2020 Jan; 12(1):16. PubMed ID: 31959227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
    Schroth W; Winter S; Büttner F; Goletz S; Faißt S; Brinkmann F; Saladores P; Heidemann E; Ott G; Gerteis A; Alscher MD; Dippon J; Schwab M; Brauch H; Fritz P
    Breast Cancer Res Treat; 2016 Jan; 155(1):85-97. PubMed ID: 26650824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.